Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrike Obst

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Organic & Biomolecular Chemistry|June 10, 2006
Multipolar interactions in the D pocket of thrombin: large differences between tricyclic imide and lactam inhibitorsEliane Schweizer, Anja Hoffmann-Röder, Jacob A Olsen, et al.
Bioorganic & Medicinal Chemistry|April 20, 2006
Dose-dependent antithrombotic activity of an orally active tissue factor/factor VIIa inhibitor without concomitant enhancement of bleeding propensityKatrin Groebke Zbinden, David W Banner, Kurt Hilpert, et al.
Chemmedchem|August 8, 2006
A fluorine scan at the catalytic center of thrombin: C--F, C--OH, and C--OMe bioisosterism and fluorine effects on pKa and log D valuesEliane Schweizer, Anja Hoffmann-Röder, Kaspar Schärer, et al.
Frontiers in Cellular and Infection Microbiology|September 13, 2021
Identification and Phenotypic Characterization of Hsp90 Phosphorylation Sites That Modulate Virulence Traits in the Major Human Fungal Pathogen <i>Candida albicans</i>Leenah Alaalm, Julia L Crunden, Mark Butcher, et al.
Journal of Medicinal Chemistry|November 2, 2013
6-Alkoxy-5-aryl-3-pyridinecarboxamides, a new series of bioavailable cannabinoid receptor type 1 (CB1) antagonists including peripherally selective compoundsStephan Röver, Mirjana Andjelkovic, Agnès Bénardeau, et al.
Journal of the American Chemical Society|January 15, 2025
Confinement and Catalysis within <i>De Novo</i> Designed Peptide BarrelsRokas Petrenas, Olivia A Hawkins, Jacob F Jones, et al.
Chemmedchem|December 11, 2012
2-Phenoxy-nicotinamides are potent agonists at the bile acid receptor GPBAR1 (TGR5)Rainer E Martin, Caterina Bissantz, Olivier Gavelle, et al.
Bioorganic & Medicinal Chemistry Letters|September 24, 2016
Design and synthesis of selective, dual fatty acid binding protein 4 and 5 inhibitorsHolger Kühne, Ulrike Obst-Sander, Bernd Kuhn, et al.
Bioorganic & Medicinal Chemistry Letters|October 11, 2005
Selective and orally bioavailable phenylglycine tissue factor/factor VIIa inhibitorsKatrin Groebke Zbinden, Ulrike Obst-Sander, Kurt Hilpert, et al.
Bioorganic & Medicinal Chemistry Letters|July 9, 2013
Discovery and optimisation of 1-hydroxyimino-3,3-diphenylpropanes, a new class of orally active GPBAR1 (TGR5) agonistsHenrietta Dehmlow, Rubén Alvarez Sánchez, Stephan Bachmann, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Organic & Biomolecular Chemistry|June 10, 2006
Multipolar interactions in the D pocket of thrombin: large differences between tricyclic imide and lactam inhibitorsEliane Schweizer, Anja Hoffmann-Röder, Jacob A Olsen, et al.
Bioorganic & Medicinal Chemistry|April 20, 2006
Dose-dependent antithrombotic activity of an orally active tissue factor/factor VIIa inhibitor without concomitant enhancement of bleeding propensityKatrin Groebke Zbinden, David W Banner, Kurt Hilpert, et al.
Chemmedchem|August 8, 2006
A fluorine scan at the catalytic center of thrombin: C--F, C--OH, and C--OMe bioisosterism and fluorine effects on pKa and log D valuesEliane Schweizer, Anja Hoffmann-Röder, Kaspar Schärer, et al.
Frontiers in Cellular and Infection Microbiology|September 13, 2021
Identification and Phenotypic Characterization of Hsp90 Phosphorylation Sites That Modulate Virulence Traits in the Major Human Fungal Pathogen <i>Candida albicans</i>Leenah Alaalm, Julia L Crunden, Mark Butcher, et al.
Journal of Medicinal Chemistry|November 2, 2013
6-Alkoxy-5-aryl-3-pyridinecarboxamides, a new series of bioavailable cannabinoid receptor type 1 (CB1) antagonists including peripherally selective compoundsStephan Röver, Mirjana Andjelkovic, Agnès Bénardeau, et al.
Journal of the American Chemical Society|January 15, 2025
Confinement and Catalysis within <i>De Novo</i> Designed Peptide BarrelsRokas Petrenas, Olivia A Hawkins, Jacob F Jones, et al.
Chemmedchem|December 11, 2012
2-Phenoxy-nicotinamides are potent agonists at the bile acid receptor GPBAR1 (TGR5)Rainer E Martin, Caterina Bissantz, Olivier Gavelle, et al.
Bioorganic & Medicinal Chemistry Letters|September 24, 2016
Design and synthesis of selective, dual fatty acid binding protein 4 and 5 inhibitorsHolger Kühne, Ulrike Obst-Sander, Bernd Kuhn, et al.
Bioorganic & Medicinal Chemistry Letters|October 11, 2005
Selective and orally bioavailable phenylglycine tissue factor/factor VIIa inhibitorsKatrin Groebke Zbinden, Ulrike Obst-Sander, Kurt Hilpert, et al.
Bioorganic & Medicinal Chemistry Letters|July 9, 2013
Discovery and optimisation of 1-hydroxyimino-3,3-diphenylpropanes, a new class of orally active GPBAR1 (TGR5) agonistsHenrietta Dehmlow, Rubén Alvarez Sánchez, Stephan Bachmann, et al.
Pageof 3